2019 Speakers for the Preparing for Science-Based Non-Traditional Careers Course
February 13 - Rosemarie Truman
Founder and CEO of the Center for Advancing Innovation
Topic: “Alternative Careers for PhDs - In Particular Consulting"
Rosemarie Truman is an entrepreneur, growth strategist, distinguished corporate executive, angel investor and prolific startup catalyst. Rosemarie Truman is Founder and CEO of the Center for Advancing Innovation (CAI), a 501c3 non-profit which has been coined “Tinder for Startups” and “Shark Tank on Steroids.” CAI’s mission to identify breakthrough inventions and maximize their commercial potential. With over 25 years of experience in entrepreneurship, executive leadership, and philanthropy, Rosemarie’s specialty is growth and investment strategy, having led growth strategies for 50 of the global Fortune 100 companies in over 15 countries. The strategies that Rosemarie led have resulted in $300+ billion in “net new” top line yearly revenue and 190+ new products on the market.
For her clients and CAI, Rosemarie pioneers innovative, award-winning, disruptive innovation platforms. One of her recent endeavors is a novel challenge-accelerator model that has established a new paradigm for commercializing federally-funded inventions, galvanizing ecosystems, and creating knowledge-based jobs. In three short years, Rosemarie’s challenge-accelerator model has created 80+ companies, 2000+ entrepreneurs, 25+ partnerships, collaborations across federal labs and government agencies, and new business model architectures for obtaining inventions. With this recent initiative, Rosemarie also conceived of, engineered and launched five “first of a kind” challenges to crowdsource startup teams to advance federally-funded inventions through CAI. These challenges produced 80 new startup companies, 24% of which are led by women founders.
Under Rosemarie’s leadership, CAI has earned numerous awards and recognition from Health and Human Services, the White House, the Federal Laboratory Consortium and more. CAI has also been featured in the Washington Post, Wired, Huffington Post, Nature, and several other publications. Rosemarie also serves as Director of the DC-metro chapter of the Founder Institute, the world’s largest startup accelerator program. Prior to launching her own firm, Rosemarie spearheaded IBM’s Innovation strategy practice globally. At IBM, she was awarded IBM’s most laudable honor, the Golden Circle Award. In addition, she has also held notable leadership roles at Booz Allen Hamilton, Oracle, PRTM, and Marsh & McLennan, where she served as VP of global strategy. Rosemarie began her career at Goldman Sachs. Her core competencies are in leadership, strategy consulting, investment banking and entrepreneurship.
February 20 - John Greene, PhD and Felix Yu, PhD
John Greene, PhD
Senior Scientific Executive
Booz Allen Hamilton
Title: “Booz Allen Hamilton: Where Consulting and Innovation Meet”
John Greene is a senior scientific executive with comprehensive expertise in bioinformatics at Booz Allen Hamilton. Dr. Greene began his academic journey at MIT and pursued his Ph.D. from Harvard where between both institutes, he was trained by 6 Nobel laureates. After his scientific training, Dr. Greene has worked as a molecular biologist with 26 years of industry experience including Human Genome Sciences, where he was the first Bioinformatics Scientist and discovered TIMP-4 (VasoSten™) for restenosis therapy, among eight novel human genes. Prior to Booz Allen, Dr. Greene formerly serve as Chief of Bioinformatics at GDIT (previously CSRA and SRA International), he assisted management in determining strategy and partnering for business development, in proposing bioinformatics systems functionality, and in recruiting new staff for the bioinformatics business. Amongst many of Dr. Greene’s experiences, he was responsible for numerous NIH projects that include NCI’s TARGET pediatric cancer Data Coordinating Center (Senior Program Manager) and the Cancer Genome Atlas (TCGA) (Principal Investigator). He also consulted for NHLBI on TopMED data cloud migration and for the NIAID Enteropathogen Resource Integration Center. Dr. Greene is also an Adjunct Faculty at The Johns Hopkins University, where he has taught courses for 19 years.
Felix Yu, PhD
Booz Allen Hamilton
Felix Yu is a Senior Consultant and Health Data Subject Matter Expert at Booz Allen Hamilton. Prior to Booz Allen, Felix completed his bachelor’s degree in Chemistry and Ph.D. in Chemical Biology from Texas A&M University and Johns Hopkins University respectively. At Hopkins (PI: Jun O. Liu), he discovered a novel small molecule activator of actin-dependent YAP signaling as a potential drug lead for regenerative medicine. As a graduate student, Felix has also led multiple student-ran organizations raising over $30K in total funding and spearheaded six pro-bono consulting projects, including works with Pfizer and the Baltimore City Council. In the final years of his graduate career, Felix interned with Booz Allen, where he worked on capturing NIH-NCI opportunities, securing partnership with nationwide voluntary health organizations, and developing native language processing capabilities for life science research tools. As a full-time employee, Felix continues to offer his scientific research and healthcare expertise to support Booz Allen’s businesses and clients in the federal health space. Felix is currently assisting FDA’s Center for Drug Evaluation and Research (CDER) in adopting modernized technology to improve efficiency and decision-making during drug review processes. Topics to be covered:
- Booz Allen Hamilton's Business: overall missions, federal business, innovative engineering, commercial business
- History of Booz Allen Hamilton in life science research and public health
- Career at Booz Allen Hamilton - life of a scientist or a PhD/Fellow with basic science background
February 27 - Harry Greenspun, MD and Marguerite Clarkson, PhD, PMP, CCMP
Harry Greenspun, MD
Partner Chief Medical Officer
Title: “Navigating your career in the future of healthcare”
Harry Greenspun, MD is a physician executive focusing on healthcare transformation. He currently serves as Partner and Chief Medical Officer at Guidehouse. Harry has held several leadership roles at healthcare, consulting, and technology firms, including Deloitte and Dell. He serves on numerous boards and is recognized for his thought leadership and publications, including the book he co-authored, “Reengineering Healthcare: A Manifesto for Radically Rethinking Health Care Delivery.”
Harry received his bachelor’s degree from Harvard University and his medical degree from the University of Maryland. He completed his residency at Johns Hopkins Hospital, where he was Chief Resident, and has practiced cardiac anesthesiology in hospitals throughout the area. When he is not working to improve health and healthcare, he enjoys cycling and is President of Rock Creek Velo, a local youth cycling club.
Marguerite Clarkson, PhD, PMP, CCMP
Marguerite Clarkson, PhD., PMP, CCMP is a manager at Guidehouse and provides a range of advisory services, from human capital and change management to business process improvement and organizational effectiveness. She has led teams supporting the NIH Clinical Center, NCI, NIAID, NIMH and other NIH Institutes and Centers and Centers across FDA. Prior to joining Guidehouse, Marguerite was a postdoctoral fellow at NIH NIAAA investigating the genetic and neural systems that are compromised in post-traumatic stress disorder and alcohol dependence.
Marguerite received her bachelor’s degree in psychology from The University of North Carolina at Chapel Hill and her Ph.D. in neuroscience from The University of Texas at Austin. Outside of the office, Marguerite enjoys running, reading, spending time with family and keeping up with her two young children.
Topics to be covered:
- The future of healthcare and what it means for new scientists entering the workforce
- From M.D./Ph.D. to management consultant and tips for making the move
- Opportunities for scientists in management consulting
March 6 - Juergen Klenk, PhD
Principal in Deloitte’s Federal Health Sector
Title: “What to do with a PhD in the Consulting Industry”
Juergen Klenk is a Principal in Deloitte’s Federal Health Sector. He has a deep technical expertise combined with strong business acumen and a track record of over 20 years of experience in leadership, strategic planning, business development, consulting, project management, science and technology, analytics, and research. Dr. Klenk is a highly experienced entrepreneur and thought leader who has demonstrated the ability to start up, grow, and successfully establish innovative businesses in the Health sector. He has successfully led teams across a wide variety of health and science focused organizations. Throughout his career, Dr. Klenk has worked with some of the leading organizations in health care and life sciences, including the federal government (e.g., NIH, FDA, CDC, CMS, and VA), academic medical centers, commercial health care providers, pharmaceutical and biotech companies, and nonprofit organizations. For the past 15 years his work was focused on topics including precision medicine, health data integration and analysis, clinical trials support and optimization, health outcomes research, and scientific research and innovation. Dr. Klenk has authored numerous publications in peer-reviewed journals, holds multiple patents, and has been invited to present at multiple international conferences. He holds a Ph.D. in Mathematics and a master’s degree in Mathematics and Physics from Eberhard-Karls-Universität Tübingen (Germany). He spent his academic career at Eberhard-Karls-Universität Tübingen, the Australian National University, and Yale University.
March 13 - Kelly Lyn Warfield, PhD
Antiviral Research and Development Emergent Virology LLC
Title: “Preparing for a career in the industry”
Dr. Kelly Lyn Warfield began her scientific career as a student intern at the National Institute of Standards and Technologies and National Cancer Institute. Following college at Loyola University, Maryland, Dr. Warfield received her Ph.D. degree in molecular virology from Baylor College of Medicine in Houston, Texas studying immune responses, pathogenesis and adverse events related to rotavirus vaccination and infection. During a National Research Council postdoctoral fellowship at the United States Army Medical Research Institute of Infectious Diseases, Dr. Warfield became specially trained in BSL-3 and BSL-4 containment laboratories studying pathogenesis, developing animal models and vaccines and therapeutics for the highly lethal filoviruses. Dr. Warfield transitioned to the biotechnology industry by co-founding the start-up company Integrated Biotherapeutics, Inc. and was the Vice President of Vaccine Development for 6 years with a focus on development of antivirals and vaccines for Ebola and Marburg viruses. Currently, she is the Senior Director of Antiviral Research and Development at Emergent Virology with responsibility for the preclinical development activities for broad-spectrum antivirals with indications including uncomplicated dengue, influenza and other acute virus infections.
Topics to be covered include:
- Transitioning from academic research to industry
- Differences between academia and industry
- What can a PhD do in the industry?
- How do you prepare yourself for a career in industry?
- Learning project management
- Working in a matrix and team-oriented atmosphere
- Managing multiple projects and deadlines in a fast-paced environment
- Delivering results and managing expectations
- Written and verbal communication skills
March 20 - Monique Small, PharmD
Regulatory Affairs Director
Global Regulatory Affairs
Title: “Regulatory Affairs as a Science-Based Career in Drug Development”
Dr. Small is the Director for Global Regulatory Affairs at AstraZeneca. She has over 20 years of experience in various pharmaceutical industries. She has a BS and Doctorate degree in Pharmacy from the University of South Carolina. Before joining the pharmaceutical industry she interned at FDA’s Office of Special Health Issues.
Topic(s) to be discussed:
- Regulatory affairs as a career for scientists
March 27 - Brandy Heckman-Stoddard, PhD, MPH
Division of Cancer Prevention
National Cancer Institute
Title: “Navigating USA Jobs”
Dr. Heckman-Stoddard received a Doctor of Philosophy degree in Molecular and Cellular Biology at Baylor College of Medicine focusing on the intersection of Rho and IGF signaling in mammary gland development and breast cancer before joining the National Cancer Institute as a Cancer Prevention Fellow. During the fellowship she completed a Master's in Public Health at the Johns Hopkins Bloomberg School of Public Health working with the Institute for Global Tobacco Control and the Evidence-Based Practice Center. During her time at NCI as a fellow, she focused on breast cancer prevention research including preclinical development and early clinical trials.
Dr. Heckman-Stoddard's research focuses on drug development for breast cancer prevention and biomarker development. She is particularly interested in local delivery of agents, alternate dosing strategies, biomarkers of efficacy to reduce the number needed to treat, and targeting of stem cells. She serves as program director for the Early Phase Breast Cancer Prevention Clinical Trials grants portfolio and scientific monitor of early phase breast cancer clinical trials within the NCI Division of Cancer Prevention Early Phase Prevention Consortia. Dr. Heckman-Stoddard is also the NCI lead for an NCI-NIDDK collaboration examining cancer incidence within the Diabetes Prevention Program Outcomes Study a randomized study of metformin, lifestyle intervention, versus placebo.
Topics to be covered:
- applying to USA Jobs
- how to find keywords and tailor your resume